🎤 Join our founder group to hear from firms like NEA on What it takes to raise a Series A?

Register
Chong Xu

Chong Xu

Partner·F-Prime

Cambridge, MA, USA

Bio

Professional summary

Chong Xu is a Partner at F-Prime focused primarily on biopharmaceutical and medical technology investments. He works with Eight Roads Ventures Asia on portfolio companies and new investment opportunities in China, and has been involved in company formations including AlphaGen Tx, Pediatrix, Skyline Tx, K36 Tx, and RareStone Group. Before joining F-Prime in 2015, he worked at McKinsey, as a healthcare equity analyst at Massif Partners and Affirmed Healthcare, and as a developmental neurobiology researcher at Temasek Life Sciences Laboratory.

Notable companies

Selected portfolio companies the partner has backed

AlphaGen TxPediatrixSkyline TxK36 TxRareStone Group

Background

Career, education, and skills

Career history

  • F-Prime CapitalPartner2015 – Present
  • McKinsey & CompanyManagement Consultant
  • Massif PartnersHealthcare Equity Analyst
  • Affirmed HealthcareHealthcare Equity Analyst
  • Temasek Life Sciences LaboratoryResearcher

Education

  • University of Virginia Darden School of BusinessMBA
  • University of VirginiaPhD in Cell Biology
  • Zhejiang UniversityBS in Biology

Other partners at F-Prime

12 more profiles

Abdul Abdirahman

Abdul Abdirahman

Principal

F-Prime

Principal investing in early-stage B2B software, fintech, and vertical SaaS.

B2B softwareEarly-stage investingEmerging marketsFintechVertical SaaS
Alex Pasteur

Alex Pasteur

Partner

F-Prime

Alex Pasteur is a London-based Partner at F-Prime Capital focused on therapeutics and life sciences.

Life SciencesTherapeutics
AP

Anastasiya Sybirna, PhD

Senior Associate

F-Prime

Senior Associate on F-Prime's London healthcare investment team.

BiopharmaHealthcareLife sciencesPharmaceuticalsTherapeutics
Bala Varadhan

Bala Varadhan

Principal

F-Prime

Principal focused on early-stage crypto, blockchain and Web3 investments.

BlockchainCryptoDigital assetsEarly-stage investingWeb3
Benjamin Gorman

Benjamin Gorman

Principal

F-Prime

Principal investing in early-stage enterprise software and AI.

AIDataEarly-stage investingEnterprise softwareMachine learning
Betsy Mulé

Betsy Mulé

Principal

F-Prime

Principal investing in enterprise technology and robotics.

B2B softwareEarly-stage investingEnterprise technologyFrontier technologyRobotics
Brett Cook

Brett Cook

Partner

F-Prime

F-Prime Partner investing in healthcare technology and services companies.

care deliverydigital healthhealthcare datahealthcare serviceshealthcare technology
Brian Yordy

Brian Yordy

Principal

F-Prime

Principal investing in biopharmaceutical and medical technology companies.

BiopharmaceuticalsHealthcareLife sciencesMedical technologyTherapeutics
Carl Bradford Byers 🚑

Carl Bradford Byers 🚑

Partner

F-Prime

F-Prime Partner and former athenahealth founding CFO investing in healthcare IT and digital health.

digital healthfintechhealthcare IThealthcare serviceshealthtech
Carl Byers

Carl Byers

Partner

F-Prime

Carl Byers is a Partner at F-Prime Capital with significant operating experience in healthcare IT, including as a founding team member and CFO of athenahealth.

HealthtechServices
Chance Mathisen

Chance Mathisen

Associate

F-Prime

Associate focused on early-stage enterprise software investments.

AIEarly-stage investingEnterprise softwareGo-to-market strategySoftware platforms
Connie Li

Connie Li

Principal

F-Prime

Principal on F-Prime's life sciences team focused on biotechnology.

BiotechnologyChina healthcareCompany formationLife sciencesTherapeutics